243 related articles for article (PubMed ID: 10397747)
1. Overexpression of wild-type retinoic acid receptor alpha (RARalpha) recapitulates retinoic acid-sensitive transformation of primary myeloid progenitors by acute promyelocytic leukemia RARalpha-fusion genes.
Du C; Redner RL; Cooke MP; Lavau C
Blood; 1999 Jul; 94(2):793-802. PubMed ID: 10397747
[TBL] [Abstract][Full Text] [Related]
2. Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia.
Grignani F; De Matteis S; Nervi C; Tomassoni L; Gelmetti V; Cioce M; Fanelli M; Ruthardt M; Ferrara FF; Zamir I; Seiser C; Grignani F; Lazar MA; Minucci S; Pelicci PG
Nature; 1998 Feb; 391(6669):815-8. PubMed ID: 9486655
[TBL] [Abstract][Full Text] [Related]
3. Distinct leukemia phenotypes in transgenic mice and different corepressor interactions generated by promyelocytic leukemia variant fusion genes PLZF-RARalpha and NPM-RARalpha.
Cheng GX; Zhu XH; Men XQ; Wang L; Huang QH; Jin XL; Xiong SM; Zhu J; Guo WM; Chen JQ; Xu SF; So E; Chan LC; Waxman S; Zelent A; Chen GQ; Dong S; Liu JX; Chen SJ
Proc Natl Acad Sci U S A; 1999 May; 96(11):6318-23. PubMed ID: 10339585
[TBL] [Abstract][Full Text] [Related]
4. Opposite effects of the acute promyelocytic leukemia PML-retinoic acid receptor alpha (RAR alpha) and PLZF-RAR alpha fusion proteins on retinoic acid signalling.
Ruthardt M; Testa U; Nervi C; Ferrucci PF; Grignani F; Puccetti E; Grignani F; Peschle C; Pelicci PG
Mol Cell Biol; 1997 Aug; 17(8):4859-69. PubMed ID: 9234742
[TBL] [Abstract][Full Text] [Related]
5. Amino-terminal protein-protein interaction motif (POZ-domain) is responsible for activities of the promyelocytic leukemia zinc finger-retinoic acid receptor-alpha fusion protein.
Dong S; Zhu J; Reid A; Strutt P; Guidez F; Zhong HJ; Wang ZY; Licht J; Waxman S; Chomienne C; Chen Z; Zelent A; Chen SJ
Proc Natl Acad Sci U S A; 1996 Apr; 93(8):3624-9. PubMed ID: 8622986
[TBL] [Abstract][Full Text] [Related]
6. Leukemic transformation by the APL fusion protein PRKAR1A-RAR{alpha} critically depends on recruitment of RXR{alpha}.
Qiu JJ; Lu X; Zeisig BB; Ma Z; Cai X; Chen S; Gronemeyer H; Tweardy DJ; So CW; Dong S
Blood; 2010 Jan; 115(3):643-52. PubMed ID: 19965660
[TBL] [Abstract][Full Text] [Related]
7. Distinct interactions of PML-RARalpha and PLZF-RARalpha with co-repressors determine differential responses to RA in APL.
He LZ; Guidez F; Tribioli C; Peruzzi D; Ruthardt M; Zelent A; Pandolfi PP
Nat Genet; 1998 Feb; 18(2):126-35. PubMed ID: 9462740
[TBL] [Abstract][Full Text] [Related]
8. Acute leukemia with promyelocytic features in PML/RARalpha transgenic mice.
He LZ; Tribioli C; Rivi R; Peruzzi D; Pelicci PG; Soares V; Cattoretti G; Pandolfi PP
Proc Natl Acad Sci U S A; 1997 May; 94(10):5302-7. PubMed ID: 9144232
[TBL] [Abstract][Full Text] [Related]
9. PIC-1/SUMO-1-modified PML-retinoic acid receptor alpha mediates arsenic trioxide-induced apoptosis in acute promyelocytic leukemia.
Sternsdorf T; Puccetti E; Jensen K; Hoelzer D; Will H; Ottmann OG; Ruthardt M
Mol Cell Biol; 1999 Jul; 19(7):5170-8. PubMed ID: 10373566
[TBL] [Abstract][Full Text] [Related]
10. The theory of APL.
Piazza F; Gurrieri C; Pandolfi PP
Oncogene; 2001 Oct; 20(49):7216-22. PubMed ID: 11704849
[TBL] [Abstract][Full Text] [Related]
11. Deregulation of NPM and PLZF in a variant t(5;17) case of acute promyelocytic leukemia.
Hummel JL; Wells RA; Dubé ID; Licht JD; Kamel-Reid S
Oncogene; 1999 Jan; 18(3):633-41. PubMed ID: 9989813
[TBL] [Abstract][Full Text] [Related]
12. Interactions of STAT5b-RARalpha, a novel acute promyelocytic leukemia fusion protein, with retinoic acid receptor and STAT3 signaling pathways.
Dong S; Tweardy DJ
Blood; 2002 Apr; 99(8):2637-46. PubMed ID: 11929748
[TBL] [Abstract][Full Text] [Related]
13. Targeting the acute promyelocytic leukemia-associated fusion proteins PML/RARα and PLZF/RARα with interfering peptides.
Beez S; Demmer P; Puccetti E
PLoS One; 2012; 7(11):e48636. PubMed ID: 23152790
[TBL] [Abstract][Full Text] [Related]
14. Transgenic expression of PML/RARalpha impairs myelopoiesis.
Early E; Moore MA; Kakizuka A; Nason-Burchenal K; Martin P; Evans RM; Dmitrovsky E
Proc Natl Acad Sci U S A; 1996 Jul; 93(15):7900-4. PubMed ID: 8755574
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive genomic screens identify a role for PLZF-RARalpha as a positive regulator of cell proliferation via direct regulation of c-MYC.
Rice KL; Hormaeche I; Doulatov S; Flatow JM; Grimwade D; Mills KI; Leiva M; Ablain J; Ambardekar C; McConnell MJ; Dick JE; Licht JD
Blood; 2009 Dec; 114(27):5499-511. PubMed ID: 19855079
[TBL] [Abstract][Full Text] [Related]
16. The self-association coiled-coil domain of PML is sufficient for the oncogenic conversion of the retinoic acid receptor (RAR) alpha.
Occhionorelli M; Santoro F; Pallavicini I; Gruszka A; Moretti S; Bossi D; Viale A; Shing D; Ronzoni S; Muradore I; Soncini M; Pruneri G; Rafaniello P; Viale G; Pelicci PG; Minucci S
Leukemia; 2011 May; 25(5):814-20. PubMed ID: 21331069
[TBL] [Abstract][Full Text] [Related]
17. Retinoic acid (RA) and As2O3 treatment in transgenic models of acute promyelocytic leukemia (APL) unravel the distinct nature of the leukemogenic process induced by the PML-RARalpha and PLZF-RARalpha oncoproteins.
Rego EM; He LZ; Warrell RP; Wang ZG; Pandolfi PP
Proc Natl Acad Sci U S A; 2000 Aug; 97(18):10173-8. PubMed ID: 10954752
[TBL] [Abstract][Full Text] [Related]
18. Characterisation of the PML/RAR alpha rearrangement associated with t(15;17) acute promyelocytic leukaemia.
Grimwade D; Solomon E
Curr Top Microbiol Immunol; 1997; 220():81-112. PubMed ID: 9103677
[TBL] [Abstract][Full Text] [Related]
19. Leukemia with distinct phenotypes in transgenic mice expressing PML/RAR alpha, PLZF/RAR alpha or NPM/RAR alpha.
Rego EM; Ruggero D; Tribioli C; Cattoretti G; Kogan S; Redner RL; Pandolfi PP
Oncogene; 2006 Mar; 25(13):1974-9. PubMed ID: 16331271
[TBL] [Abstract][Full Text] [Related]
20. Retinoid-induced differentiation of acute promyelocytic leukemia involves PML-RARalpha-mediated increase of type II transglutaminase.
Benedetti L; Grignani F; Scicchitano BM; Jetten AM; Diverio D; Lo Coco F; Avvisati G; Gambacorti-Passerini C; Adamo S; Levin AA; Pelicci PG; Nervi C
Blood; 1996 Mar; 87(5):1939-50. PubMed ID: 8634442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
